Home
Home
About
Contact
Begin your search of the AGOSR Open Access Database
Search
Reset
All Fields
Contributors
DOI
OAI
Results: 1
View Article
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Can G Leineweber
,
Miriam Rabehl
,
Anne Pietzner
,
Nadine Rohwer
,
Michael Rothe
,
Maciej Pech
,
Bruno Sangro
,
Rohini Sharma
,
Chris Verslype
,
Bristi Basu
,
Christian Sengel
,
Jens Ricke
,
Nils Helge Schebb
,
Karsten-H Weylandt
,
Julia Benckert
Mar 17, 2023
EDP
EET
Cytochrome P450
hepatocellular carcinoma
lipidomics
Omega-3 fatty acids
Oxylipins
Sorafenib
Published by:
